155 related articles for article (PubMed ID: 7579461)
21. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
Wu F; Wang X; Zhao W; Wang H; Shen Z
Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
[TBL] [Abstract][Full Text] [Related]
22. [The impact of arsenic trioxide or all-trans retinoic acid treatment on coagulopathy in acute promyelocytic leukemia].
Zhang X; Zhou H; Song S; Qiao Z; Yang L; Hu Y
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):829-33. PubMed ID: 16206674
[TBL] [Abstract][Full Text] [Related]
23. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
[TBL] [Abstract][Full Text] [Related]
24. All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties.
Marchetti M; Vignoli A; Bani MR; Balducci D; Barbui T; Falanga A
Haematologica; 2003 Aug; 88(8):895-905. PubMed ID: 12935977
[TBL] [Abstract][Full Text] [Related]
25. All-trans-retinoic acid induces CD52 expression in acute promyelocytic leukemia.
Li SW; Tang D; Ahrens KP; She JX; Braylan RC; Yang L
Blood; 2003 Mar; 101(5):1977-80. PubMed ID: 12393392
[TBL] [Abstract][Full Text] [Related]
26. Laminin promotes differentiation of NB4 promyelocytic leukemia cells with all-trans retinoic acid.
Becker PS; Li Z; Potselueva T; Madri JA; Newburger PE; Berliner N
Blood; 1996 Jul; 88(1):261-7. PubMed ID: 8704182
[TBL] [Abstract][Full Text] [Related]
27. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
28. Urokinase inhibits HL-60 cell proliferation in vitro.
Howell AL; Hunt JA; James TW; Mazar A; Henkin J; Zacharski LR
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):445-53. PubMed ID: 7841298
[TBL] [Abstract][Full Text] [Related]
29. Annexin II and bleeding in acute promyelocytic leukemia.
Menell JS; Cesarman GM; Jacovina AT; McLaughlin MA; Lev EA; Hajjar KA
N Engl J Med; 1999 Apr; 340(13):994-1004. PubMed ID: 10099141
[TBL] [Abstract][Full Text] [Related]
30. The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia.
Miyauchi J; Inatomi Y; Ohyashiki K; Asada M; Mizutani S; Toyama K
Leuk Res; 1997 Apr; 21(4):285-94. PubMed ID: 9150345
[TBL] [Abstract][Full Text] [Related]
31. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
32. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
33. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
[TBL] [Abstract][Full Text] [Related]
34. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase.
Benedetti L; Grignani F; Scicchitano BM; Jetten AM; Diverio D; Lo Coco F; Avvisati G; Gambacorti-Passerini C; Adamo S; Levin AA; Pelicci PG; Nervi C
Blood; 1996 Mar; 87(5):1939-50. PubMed ID: 8634442
[TBL] [Abstract][Full Text] [Related]
35. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Niitsu N; Higashihara M; Honma Y
Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
[TBL] [Abstract][Full Text] [Related]
36. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
[TBL] [Abstract][Full Text] [Related]
37. PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells.
Tenno T; Oberg F; Mackman N; Nilsson K; Siegbahn A
Thromb Haemost; 2003 Nov; 90(5):930-9. PubMed ID: 14597990
[TBL] [Abstract][Full Text] [Related]
38. [Tissue factor expression during all-trans retinoic acid or arsenic trioxide treatment in acute promyelocytic leukemia].
Zhao W; Wang H; Guo W
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):473-6. PubMed ID: 11189487
[TBL] [Abstract][Full Text] [Related]
39. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
[TBL] [Abstract][Full Text] [Related]
40. [Effects of realgar on tissue factor expression of NB4 and MR2 cells].
Zhao XA; Liu SX
Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):553-6. PubMed ID: 15015339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
